Life sciences firms see some fundraising success but need massive sums
Around Indiana, life sciences companies are searching high and low for venture capital to fund promising but expensive new products, which can take a decade or longer to develop.
David Johnson
Articles
IBJ Life Sciences Power Breakfast transcript – 2016
IBJ gathered leaders in the life sciences industry for a Power Breakfast panel discussion April 21. Panel members included Colleen Hittle, managing director of Navigant; Suresh Garimella, Purdue University’s executive vice president of research and partnerships; Brian Barker, general manager of U.S. Seeds for Dow AgroSciences; Kristin Sherman, former chief financial officer of Calibrium LLC; and David Johnson, CEO of BioCrossroads.
Lilly Endowment gives $2.9M more to BioCrossroads
Including the latest grant, the Lilly Endowment has given more than $38 million to BioCrossroads since the life sciences business development group was founded in 2002.
Ballard education deputy leaving to head up workforce initiative
Jason Kloth, who has been Mayor Greg Ballard’s deputy mayor for education since 2012, will step down Friday to lead a workforce development effort being launched by the Central Indiana Corporate Partnership.
Life sciences panel: Indiana making headway but needs more capital
The state has enjoyed success funding and building life sciences companies, and the new Indiana Biosciences Research Institute should give it a further boost, according to panelists Friday at IBJ's Life Sciences Power Breakfast.
Jury returns guilty verdicts in Land Bank case
A federal jury on Wednesday evening returned guilty verdicts on eight felony counts including wire fraud and bribery against Reggie Walton, a former city employee who managed the Indy Land Bank.
Former Land Bank chief grilled over inconsistent testimony
Former Indy Land Bank director Reggie Walton opted to take the stand in his own defense in federal court this week, and prosecutors took the opportunity to use his words against him.
Third defendant pleads guilty on eve of Land Bank trial
A third defendant in an alleged kickback scheme involving the Indy Land Bank has pleaded guilty on the eve of a trial set for the first week of March.
Stick to business reporting
I’m puzzled by your [Sept. 16] stories “The Brain Drain is a Myth” and “Too Few Jobs for Science, Tech Graduates” and their excessively academic focus on the very practical issue of why there are too few Hoosiers working in high-paying jobs to power our state’s future.
Commission OK’d land bank deals with charities
City development officials were outraged last year to learn that the Indy Land Bank allowed investors to circumvent a public bidding process for real estate by working through a not-for-profit entity. Yet they continued to approve Land Bank transactions with not-for-profits.
Feds used wire tap, undercover agent in Land Bank probe
A federal public-corruption task force used a wire tap and an undercover FBI agent to unravel a fraud scheme authorities say was orchestrated by two city employees and three co-conspirators.
Feds charge 5 in Indy Land Bank kickback scheme
Federal prosecutors have charged two city employees in the Department of Metropolitan Development and three others in a scheme involving cash kickbacks on the sale of properties in the Indy Land Bank.
Health care startups hungry for funds
Frustrated by up-and-down state funding for startup life sciences companies, industry leaders are talking up a plan to create a dedicated funding stream that could total $30 million a year.
Indiana firms see big drop in venture funding
Venture capital investments in Indiana dropped off in 2012, but local investors see the market here steadily gaining strength.
Johnson picked to succeed Miles as leader of CICP
BioCrossroads CEO David Johnson has been chosen president and CEO of the Central Indiana Corporate Partnership, succeeding Mark Miles, who is leaving the CICP after seven years to become CEO of Hulman & Co.
Indiana life sciences companies rethink innovation
Research and development comes under pressure in an age of austerity.
Indiana life sciences leaders look toward the future
Former Eli Lilly and Co. vice president Richard Dimarchi, BioCrossroads President David Johnson, angel investor Oscar Moralez and Purdue University Senior Vice President Alan Rebar discuss issues ranging from the depth of the life sciences industry in Indiana to venture capital and Purdue’s Discovery Park.
More life sciences firms opt to launch products in Europe
The U.S. Food and Drug Administration’s growing reputation for unpredictability is spurring some Indianapolis companies to join counterparts elsewhere and introduce products in Europe. The upshot is that some Americans may never benefit from innovations occurring in their backyards.
Tech district could boost Indianapolis’ convention business
The Indianapolis Convention & Visitors Association plans to attract more life sciences conferences.
Indianapolis startup attacks Alzheimer’s disease
AgeneBio Inc. this month landed a $300,000 investment from the Indiana Seed Fund to fund operations, bolster its intellectual
property, and begin learning how to make a drug into a once-a-day pill.